144 related articles for article (PubMed ID: 11705770)
1. Splanchnic blood flow and hepatic glucose production in exercising humans: role of renin-angiotensin system.
Bergeron R; Kjaer M; Simonsen L; Bülow J; Skovgaard D; Howlett K; Galbo H
Am J Physiol Regul Integr Comp Physiol; 2001 Dec; 281(6):R1854-61. PubMed ID: 11705770
[TBL] [Abstract][Full Text] [Related]
2. Effects of angiotensin blockade on the splanchnic circulation in normotensive humans.
Stadeager C; Hesse B; Henriksen O; Christensen NJ; Bonde-Petersen F; Mehlsen J; Giese J
J Appl Physiol (1985); 1989 Aug; 67(2):786-91. PubMed ID: 2551874
[TBL] [Abstract][Full Text] [Related]
3. Effects of ACE inhibition with cilazapril on splanchnic and systemic haemodynamics in man.
Gasic S; Heinz G; Kleinbloesem C; Korn A
Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):225S-234S. PubMed ID: 2548552
[TBL] [Abstract][Full Text] [Related]
4. Autonomy of the renin system in type II diabetes mellitus: dietary sodium and renal hemodynamic responses to ACE inhibition.
De'Oliveira JM; Price DA; Fisher ND; Allan DR; McKnight JA; Williams GH; Hollenberg NK
Kidney Int; 1997 Sep; 52(3):771-7. PubMed ID: 9291199
[TBL] [Abstract][Full Text] [Related]
5. Substrate turnover during prolonged exercise in man. Splanchnic and leg metabolism of glucose, free fatty acids, and amino acids.
Ahlborg G; Felig P; Hagenfeldt L; Hendler R; Wahren J
J Clin Invest; 1974 Apr; 53(4):1080-90. PubMed ID: 4815076
[TBL] [Abstract][Full Text] [Related]
6. Effects of angiotensin II receptor blockade during exercise: comparison of losartan and saralasin.
Symons JD; Stebbins CL
J Cardiovasc Pharmacol; 1996 Aug; 28(2):223-31. PubMed ID: 8856477
[TBL] [Abstract][Full Text] [Related]
7. Contribution of splanchnic and peripheral vascular tissues to the disposal of angiotensin-II and to regional conversion rates of angiotensin-I: a pilot study in humans.
Gasic S; Kleinbloesem CH; Heinz G; Waldhäusl W
J Cardiovasc Pharmacol; 1991 Apr; 17(4):615-20. PubMed ID: 1711629
[TBL] [Abstract][Full Text] [Related]
8. Turnover and splanchnic metabolism of free fatty acids and ketones in insulin-dependent diabetics at rest and in response to exercise.
Wahren J; Sato Y; Ostman J; Hagenfeldt L; Felig P
J Clin Invest; 1984 May; 73(5):1367-76. PubMed ID: 6715541
[TBL] [Abstract][Full Text] [Related]
9. Splanchnic and leg exchange of glucose, amino acids, and free fatty acids during exercise in diabetes mellitus.
Wahren J; Hagenfeldt L; Felig P
J Clin Invest; 1975 Jun; 55(6):1303-14. PubMed ID: 1133176
[TBL] [Abstract][Full Text] [Related]
10. Splanchnic and muscle fructose metabolism during and after exercise.
Ahlborg G; Björkman O
J Appl Physiol (1985); 1990 Oct; 69(4):1244-51. PubMed ID: 2262441
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalapril.
Nussberger J; Wuerzner G; Jensen C; Brunner HR
Hypertension; 2002 Jan; 39(1):E1-8. PubMed ID: 11799102
[TBL] [Abstract][Full Text] [Related]
12. The 75-g oral glucose tolerance test: effect on splanchnic metabolism of substrates and pancreatic hormone release in healthy man.
Waldhäusl WK; Gasić S; Bratusch-Marrain P; Nowotny P
Diabetologia; 1983 Dec; 25(6):489-95. PubMed ID: 6363176
[TBL] [Abstract][Full Text] [Related]
13. The effects of angiotensin-II on lipolysis in humans.
Townsend RR
Metabolism; 2001 Apr; 50(4):468-72. PubMed ID: 11288044
[TBL] [Abstract][Full Text] [Related]
14. Impact of exogenous beta-adrenergic receptor stimulation on hepatosplanchnic oxygen kinetics and metabolic activity in septic shock.
Reinelt H; Radermacher P; Kiefer P; Fischer G; Wachter U; Vogt J; Georgieff M
Crit Care Med; 1999 Feb; 27(2):325-31. PubMed ID: 10075057
[TBL] [Abstract][Full Text] [Related]
15. Influence of angiotensin II blockade during exercise in the heat.
Mittleman KD
Eur J Appl Physiol Occup Physiol; 1996; 72(5-6):542-7. PubMed ID: 8925829
[TBL] [Abstract][Full Text] [Related]
16. Glucose metabolism during leg exercise in man.
Wahren J; Felig P; Ahlborg G; Jorfeldt L
J Clin Invest; 1971 Dec; 50(12):2715-25. PubMed ID: 5129319
[TBL] [Abstract][Full Text] [Related]
17. Comparison of blood pressure and angiotensin responses to the renin inhibitor Ro 42-5892 and the angiotensin converting enzyme inhibitor enalapril in essential hypertension.
van den Meiracker AH; Admiraal PJ; Derkx FH; Kleinbloesem C; Man in 't Veld AJ; van Brummelen P; Mulder P; Schalekamp MA
J Hypertens; 1993 Aug; 11(8):831-8. PubMed ID: 8228207
[TBL] [Abstract][Full Text] [Related]
18. Metabolic and thermodynamic responses to dehydration-induced reductions in muscle blood flow in exercising humans.
González-Alonso J; Calbet JA; Nielsen B
J Physiol; 1999 Oct; 520 Pt 2(Pt 2):577-89. PubMed ID: 10523424
[TBL] [Abstract][Full Text] [Related]
19. Differing early blood pressure and renin-angiotensin system responses to the first dose of angiotensin-converting enzyme inhibitors in congestive heart failure.
Squire IB; MacFayden RJ; Reid JL; Devlin A; Lees KR
J Cardiovasc Pharmacol; 1996 May; 27(5):657-66. PubMed ID: 8859935
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting enzyme inhibition does not suppress plasma angiotensin II increase during exercise in humans.
Aldigier JC; Huang H; Dalmay F; Lartigue M; Baussant T; Chassain AP; Leroux-Robert C; Galen FX
J Cardiovasc Pharmacol; 1993 Feb; 21(2):289-95. PubMed ID: 7679164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
